Changes in blood pressure after administration of hydroxocobalamin: Relationship to changes in plasma cobalamins-(III) concentrations in healthy volunteers

Clinical Toxicology

Volumn 46, Issue 6, 2008, Pages 551-559

  Uhl, Wolfgang ^a   Nolting, Arno ^a   Gallemann, Dieter ^a   Hecht, Stefan ^a   Kovar, Andreas ^a  

^a MERCK KGAA   (Germany)

Author keywords

Antidote; Cyanide; Pharmacodynamics

Indexed keywords

COBALAMIN DERIVATIVE; HYDROXOCOBALAMIN; PLACEBO; PLASMA PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG HALF LIFE; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VITAMIN BLOOD LEVEL;

ADULT; ANTIDOTES; AREA UNDER CURVE; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; HYDROXOCOBALAMIN; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; POISONING; TIME FACTORS; VITAMIN B 12;

EID: 46249126807     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650701829763     Document Type: Article

References (29)

1. Guidotti T. Acute cyanide poisoning in prehospital care: new challenges, new tools for intervention. Prehosp Disast Med 2006; 21 (2 suppl 2):s40-s48.
2. Dart R. Hydroxocobalamin for acute cyanide poisoning: new data from preclinical and clinical studies; new results from the prehospital emergency setting. Clin Toxicol 2006; 44(suppl 1):1-3.
3. Hall AH, Kulig KW, Rumack BH. Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. J Toxicol Clin Exp 1989; 9:3-9.
4. Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 2007; 25:551-558.
5. Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of smoke-inhalation victims treated with hydroxocobalamin. Ann Emerg Med 2007; 49:794-801.
6. Fortin J-L, Giocanti J-P, Ruttimann M, Kowalski JJ. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol 2006;44(suppl 1):37-44.
7. Dart RC, Bogdan GM. Acute cyanide poisoning: causes, consequences, recognition and management. Frontline First Responder 2004; 2:19-22.
8. Borron SW. Recognition and treatment of acute cyanide poisoning. J Emerg Nurs 2006; 32(4 suppl):S12-8.
9. Baud F, Borron S. Safety of hydroxocobalamin use in the prehospital setting as an antidote for smoke inhalation-associated cyanide poisoning. Abstract. Ann Emerg Med 2006; 48:55.
10. Forsyth JC, Mueller PD, Becker CE, Osterloh J, Benowitz NL, Rumack BH, Hall AH. Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteers. J Toxicol Clin Toxicol 1993; 31:277-294.
11. Riou B, Gerard JL, La Rochelle CD, Bourdon R, Berdeaux A, Giudicelli JF. Hemodynamic effects of hydroxocobalamin in conscious dogs. Anesthesiology 1991; 74:552-558.
12. Riou B, Berdeaux A, Pussard E, Giudicelli JF. Comparison of the hemodynamic effects of hydroxocobalamin and cobalt edetate at equipotent cyanide antidotal doses in conscious dogs. Intensive Care Med 1993; 19:26-32.
13. Borron SW, Stonerook M, Reid F. Efficacy of hydroxocobalamin for the treatment of acute cyanide poisoning in adult beagle dogs. Clin Toxicol 2006; 44(suppl 1):5-15.
14. Uhl W, Nolting A, Golor G, Rost KL, Kovar A. Safety of hydroxocobalamin in healthy volunteers in a randomized, placebo-controlled study. Clin Toxicol 2006; 44(suppl 1):17-28.
15. Gerth K, Ehring T, Braendle M, Schelling P. Nitric oxide scavenging by hydroxocobalamin may account for its hemodynamic profile. Clin Toxicol 2006; 44(suppl 1):29-36.
16. Taylor RT, Hanna ML. Binding of aquocobalamin to the histidine residues in bovine serum albumin. Arch Biochem Biophys 1970; 141:247-257.
17. Lien EL, Wood JM. The specificity of aquocobalamin-binding to bovine serum albumin.Biochim Biophys Acta 1972; 264:530-537.
18. van Kapel J, Spijkers LJ, Lindemans J, Abels J. Improved distribution analysis of cobalamins and cobalamin analogues in human plasma in which the use of thiol-blocking agents is a prerequisite. Clin Chim Acta 1983; 131:211-224.
19. Pratt JM. Inorganic chemistry of vitamin B12. Chapter 8. London: Academic Press, 1972: 114-178.
20. Gibaldi M, Perrier D. Pharmacokinetics: drugs and pharmaceutical sciences, 2nd ed, vol 15. New York: Dekker, 1982.
21. Colpaert EE, Lefebvre RA. Influence of bilirubin and other antioxidants on nitrergic relaxation in the pig gastric fundus. Br J Pharmacol 2000; 129:1201-1211.
22. Rajanayagam MA, Li CG, Rand MJ. Differential effects of hydroxocobalamin on NO-mediated relaxations in rat aorta and anococcygeus muscle. Br J Pharmacol 1993; 108:3-5.
23. Correia NA, Cavalcanti PM, Oliveira RB, Ballejo G. Effect of hydroquinone, hydroxocobalamin and carboxy-PTIO on nonadrenergic noncholinergic nerve mediated relaxations of the rat duodenum. J Auton Pharmacol 1999; 19:233-240.
24. Li CG, Rand MJ. Effects of hydroxocobalamin and carboxy-PTIO on nitrergic transmission in porcine anococcygeus and retractor penis muscles. Br J Pharmacol 1999; 127:172-176.
25. 12a) prevents and reverses endotoxin-induced hypotension and mortality in rodents: role of nitric oxide. J Pharmacol Exp Ther 1995; 273:257-265.
26. Kruszyna H, Magyar JS, Rochelle LG, Russell MA, Smith RP, Wilcox DE. Spectroscopic studies of nitric oxide interactions with cobalamins: reaction of NO with superoxocobalamin(III) likely accounts for cobalamin reversal of the biological effects of NO. J Pharmacol Exp Ther 1998; 285:665-671.
27. Rochelle LG, Morana SJ, Kruszyna H, Russell MA, Wilcox DE, Smith RP. Interactions between hydroxocobalamin and nitric oxide: evidence for a redox reactions between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 1995; 275:48-52.
28. 12 and its precursor, cobinamide. Biochemistry 2003; 42:8900-8908.
29. Brouwer M, Chamulitrat W, Ferruzzi G, Sauls DL, Weinberg JB. Nitric oxide interactions with cobalamins: biochemical and functional consequences. Blood 1996; 88:1857-1864.